The effects of α-lipoic acid on immature rats with traumatic brain injury

S Ozbal1, U Cankurt, K Tugyan

  • 1Department of Histology and Embryology, Dokuz Eylul University , Izmir , Turkey.

Insights

Alpha-lipoic acid (LA) may protect young rats from traumatic brain injury (TBI). LA treatment reduced neuronal death and apoptosis in brain regions affected by TBI, suggesting a potential therapeutic benefit.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pediatric Medicine

Background:

  • Traumatic brain injury (TBI) is a significant cause of death and disability in children.
  • TBI induces oxidative stress, leading to neuronal damage and cell death (apoptosis).
  • Alpha-lipoic acid (LA) is a potent antioxidant with free radical scavenging properties.

Purpose of the Study:

  • To investigate the neuroprotective effects of alpha-lipoic acid (LA) in a rat pup model of traumatic brain injury (TBI).
  • To assess the impact of LA on neuronal survival, apoptosis, and oxidative stress markers in specific brain regions following TBI.

Main Methods:

  • A TBI contusion model was induced in 7-day-old male rat pups.
  • Animals were randomly assigned to control, TBI, or TBI + LA treatment groups.
  • LA was administered intragastrically for 2 days post-injury; brain tissues were analyzed for neuronal density, apoptosis (TUNEL, caspase-3), and oxidative stress markers (GPx, SOD, MDA).

Main Results:

  • LA treatment significantly reduced TBI-induced neuronal death in the hippocampus, prefrontal cortex, and parietal cortex.
  • The number of apoptotic cells (TUNEL- and caspase-3-positive) was decreased in LA-treated rats.
  • LA administration enhanced the activity of antioxidant enzymes, glutathione peroxidase (GPx) and superoxide dismutase (SOD), in the prefrontal cortex.

Conclusions:

  • Alpha-lipoic acid demonstrates neuroprotective effects against TBI in developing rats.
  • LA mitigates neuronal apoptosis and enhances endogenous antioxidant defenses post-TBI.
  • These findings suggest LA holds promise as a therapeutic agent for pediatric TBI.

Related Concept Videos